| Prev Close: | 69.46 |
|---|---|
| Open: | 69.54 |
| Bid: | 67.85 x 100 |
| Ask: | 69.13 x 700 |
| NAV¹: | 71.35 |
| Net Assets²: | 220.34M |
| YTD Return (Mkt)²: | 21.50% |
| Day's Range: | 67.83 - 69.54 |
|---|---|
| 52wk Range: | 45.40 - 75.44 |
| Volume: | 70,779 |
| Avg Vol (3m): | 130,705 |
| P/E (ttm)²: | 22 |
| Yield (ttm)²: |
¹As of Apr 21, 2013
²As of Mar 30, 2013
Headlines
- [video] Obesity Officially a Diseaseat CNBC(Wed 1:42PM EDT)
- [video] BlackBerry Drops After Downgradeat CNBC(Wed 1:31PM EDT)
- [video] An Anti-Competitive Decision?at CNBC(Mon, Jun 17)
- [video] Supreme Court Rules on 'Pay for Delay'at CNBC(Mon, Jun 17)
- [video] SCOTUS: Human Genes Can't Be Patentedat CNBC(Thu, Jun 13)
- [video] Buy Rite Aid or CVS?at CNBC(Thu, Jun 13)
- [video] Maria's Observation: Marriage of Tech & Health Careat CNBC(Thu, Jun 13)
- [video] Myriad Hits Historic Highat CNBC(Thu, Jun 13)
- [video] Myriad Gets Partial Win In Rulingat CNBC(Thu, Jun 13)
- Sector ETFs: Biggest Winners & Losers YTDETF Database(Thu, Jun 13)
- Zacks Investment Ideas feature highlights: Market Vectors Biotech ETF, iShares Nasdaq Biotechnology ETF, Regeneron, Celgene and First Trust Amex Biotechnology Index FundZacks(Wed, Jun 12)
- [video] Medidata CEO on Science of the Cloudat CNBC(Tue, Jun 11)
- [video] Arena Pharmaceuticals CEO on Belviqat CNBC(Tue, Jun 11)
- [video] Apple Higher After WWDCat CNBC(Tue, Jun 11)
- 3 Impressive Biotech ETFs Crushing the MarketZacks(Tue, Jun 11)
Reports
- BBH: Fundamental Valuation and Predictive Rating ReportNew Constructs, LLC(Jun 19)
- ValuEngine Industry Report for Finance-public TD INV FDValuEngine, Inc.(Jun 19)
- BIOTECH HOLDERS TR (BBH) - REPORT FOR ACTIVE TRADERSPechala's Reports(Jun 17)
